Exploring Body Roundness Index BRI in Clinical Medicine

Author: He Ye, Chief Nurse at Peking Union Medical College Hospital, Chinese Academy of Medical Sciences. Ma Fangfang, Deputy Chief Nurse of Peking Union Medical College Hospital, Chinese Academy of Medical Sciences. Xia Ying, Deputy Chief Nurse of Peking Union Medical College Hospital, Chinese Academy of Medical Sciences. Review: Shen Jianzhong, Associate Chief Physician at Peking Union Medical College Hospital, Chinese Academy of Medical Sciences. Published by: Science Popularization China. The cover image of this article is sourced from a licensed stock photo library. Reposting may lead to copyright disputes.

Exploring Body Roundness Index BRI in Clinical Medicine Introduction: The Body Roundness Index (BRI) measures trunk fat using height and waist circumference to assess metabolic disease risk. Keywords: ['Health', 'Obesity management'] As the global obesity epidemic intensifies, the limitations of the traditional body mass index (BMI) in assessing metabolic risk are becoming increasingly evident. BMI fails to distinguish between lean body mass (muscle, bone) and fat tissue, and it does not reflect the distribution characteristics of fat within the body. The Body Roundness Index (BRI), a novel metric based on human geometric morphology, integrates height and waist circumference data to quantify the degree of trunk fat accumulation, offering a fresh perspective for assessing the risk of central obesity and related metabolic diseases. This article aims to provide an in-depth analysis of the construction principles of BRI, its advantages and disadvantages compared to traditional metrics, and its clinical value and application prospects in cardiovascular metabolic diseases. Obesity is a primary risk factor for type 2 diabetes, cardiovascular diseases, non-alcoholic fatty liver, and various malignancies. However, the traditional obesity assessment system represented by BMI has significant shortcomings. For instance, individuals with a high muscle mass at the same BMI level exhibit markedly different metabolic risks compared to those with excessive fat accumulation. Furthermore, BMI struggles to identify the population with 'normal weight obesity' (NWO). Therefore, there is an urgent need in the fields of clinical medicine and public health to develop an assessment metric that accurately reflects fat distribution, particularly the accumulation of visceral fat. The Body Roundness Index (BRI) has been proposed in this context and has quickly gained validation. 1. The Construction Principles and Biological Significance of BRI: The theoretical basis of the BRI originates from the elliptical geometry model. The human torso can be approximated as a cylinder, with its cross-sectional area determined by the waist circumference. The BRI utilizes a mathematical formula to convert the ratio of waist circumference to height into a continuous value, thereby objectively describing the body's 'roundness.' Calculation formula: In this context, WC refers to waist circumference (cm), and Height refers to height (cm). Biological significance: The core value of BRI lies in its specific reflection of abdominal obesity. Abdominal fat, particularly visceral fat, is a key driving factor of metabolic disorders. Visceral fat directly impairs insulin sensitivity and accelerates atherosclerosis by releasing free fatty acids and pro-inflammatory cytokines. By measuring waist circumference, BRI indirectly captures the accumulation of visceral fat, making it a more accurate indicator of the biological basis of metabolic risk compared to BMI. Comparison and Analysis of BRI and Traditional Indicators: To comprehensively assess the effectiveness of the BRI, it will be systematically compared with BMI, waist circumference (WC), and waist-to-hip ratio (WHR). A large amount of cohort study data has confirmed that the area under the curve (AUC) of BRI is significantly higher than that of BMI and WHR in predicting all-cause mortality, cardiovascular events, and the risk of type 2 diabetes. Three, the clinical application value of BRI in cardiovascular metabolic diseases. 1. Cardiovascular Disease (CVD) Risk Prediction: Multiple prospective studies have confirmed that BRI is a strong predictor of the incidence and mortality of cardiovascular disease (CVD). The mechanism: The increase in BRI reflects the accumulation of visceral fat, which can lead to endothelial dysfunction, increased oxidative stress, and activation of inflammatory responses. All of these factors are the pathological basis of atherosclerosis. Clinical evidence: In a meta-analysis involving over 100,000 participants, each additional unit increase in BRI is associated with an approximately 12% increase in the risk of coronary heart disease and an approximately 8% increase in the risk of stroke. This correlation exists independently of BMI, indicating that BRI provides independent risk information that BMI does not cover. Early Screening for Type 2 Diabetes Mellitus (T2DM): BRI demonstrates outstanding performance in diabetes screening. Advantages: Compared to BMI, BRI reflects insulin resistance more sensitively. For individuals who are of normal BMI but have a high BRI, often referred to as 'skinny fat,' the likelihood of developing impaired glucose tolerance and type 2 diabetes (T2DM) is significantly higher than in the general population. Application suggestion: In health examination centers and grassroots medical institutions, BRI can be used as a supplementary screening tool alongside BMI. Individuals with a BRI above the threshold should be advised to undergo an oral glucose tolerance test (OGTT) for the early detection of diabetes. 3. Assessment of Non-Alcoholic Fatty Liver Disease (NAFLD): NAFLD is highly associated with abdominal obesity. BRI shows a positive correlation with liver fat content. In situations where measuring liver stiffness is not easily accessible, BRI can serve as a simple alternative indicator for assessing the severity of NAFLD and the risk of fibrosis, especially in resource-limited areas. 4. Applicable Population and Precautions: 1. Recommended key populations to focus on. Individuals at high risk for metabolic syndrome: Those with a family history of hypertension, hyperlipidemia, or hyperglycemia. Normal weight obese individuals: they have slender limbs but a protruding abdomen, with a normal BMI yet feel that their metabolism is poor. Postmenopausal women: A decline in estrogen levels leads to the redistribution of fat to the abdomen. Long-term sedentary office workers who lack exercise. 2. Limitations and Prospects: Despite the significant advantages of the Body Roundness Index (BRI), it still has certain limitations: Population Differences: The reference values for BRI need further calibration among different ethnicities, genders, and age groups. Muscle interference: For professional athletes or those engaged in extreme fitness, developed muscles may lead to a relative increase in waist circumference, which could slightly overestimate the BRI. However, this has minimal impact in the general clinical population. Lack of dynamic data: Currently, longitudinal follow-up studies on BRI are still relatively scarce, and its value in monitoring the effectiveness of disease interventions needs to be further explored. 5. Conclusion and Outlook: In summary, the Body Roundness Index (BRI) is a simple, cost-effective, and highly sensitive measure for assessing obesity. It successfully addresses the shortcomings of the traditional BMI, which focuses solely on weight rather than shape. The BRI shows significant clinical application potential in predicting risks, early screening, and risk stratification of cardiovascular metabolic diseases. In the future, with the development of big data and artificial intelligence, Body Roundness Index (BRI) is expected to integrate with wearable devices, such as smart body fat scales, to achieve automated and real-time health risk monitoring. For clinical practitioners, incorporating BRI into routine health check-up reports can not only provide a more comprehensive assessment of a patient's health status but also offer more targeted lifestyle intervention guidance, truly realizing the shift from 'treating illness' to 'preventing illness.'